SMi’s 11th annual conference on Asthma & COPD will take place on the 13th – 14th April 2015 in London, UK.

LONDON, ENGLAND, UNITED KINGDOM, January 30, 2015 /EINPresswire.com/ -- Top 10 Reasons to Attend Asthma & COPD 2015 Include:

1. EXPERTISE: At the forefront of respiratory conferences for over a decade, Asthma & COPD will once again play host to a global audience of scientific leaders, academia and respiratory professionals, providing a focal point to explore the future of therapeutics, diagnosis and care.

2. UNRIVALED SPEAKER LINE-UP: The packed agenda will feature 20 presentations including keynotes from Amgen, MedImmune, Asthma UK and Imperial College London.

3. CASE STUDIES: Hear an array of case study led addresses from industry experts such as Janssen, GSK, AstraZeneca, University of Glasgow and many more…

4. 14 HOURS OF CONTENT: Immerse into a universe of new insights on key topics such as treatment for children, personalised therapeutics, viruses in asthma and COPD, NHS challenges and "smart" inhaled devices.

5. JOIN THE DEBATE: Discuss the challenges and choices in stratified asthma therapeutics in a panel debate led by Manchester University's Senior Lecturer in Respiratory Medicine, Robert Niven.

Dr Niven leads one of 4 centres developing the severe asthma, national database programme and continues to support the Occupational Lung disease programme.

6. THE ADEPT STUDY: Janssen will be providing this years attendees with an exclusive insight into the ADEPT study in a presentation entitled: Airways disease endotyping for personalised therapeutics in asthma & COPD. The address will analyse results from the trial and discuss current and future therapeutic targets.

7. PARTNERSHIP FOCUS: Hear from Asthma UK in a keynote address entitled: Changing role of patient charities in research - what can we offer? Executive director for research and policy, Samantha Walker, will deliver unique insights into the value of multi-partner collaborations, benefits of working with charities and Asthma UK’s approach to establishing research partnerships with industry.

8. INTERACTIVE WORKSHOP: This workshop focusses on overcoming the difficulties that companies face when registering new respiratory drugs. It demonstrates that functional respiratory imaging is able to provide new detailed insights and clear performance measures that can be vital for a successful outcome of the drug development process.

9. ENABLING TECHNOLOGY: 2 exclusive keynotes with a focus on the role of personal technology and the digital economy in respiratory health. Discuss the increasingly widespread adoption of new personal health technologies, smart devices, functional lung imaging, plus much more…

10. NETWORKING: Ample opportunity for discussion, including 2 morning coffee breaks, 2 networking lunches and 2 afternoon tea sessions. Make new contacts, meet old friends and form the relationships you can count on in the future.

Further information is available online at http://www.smi-online.co.uk/goto/2015asthma-copd38.asp

Asthma & COPD 2015
13th – 14th April 2015
Holiday Inn Regents Park Hotel, London UK
http://www.smi-online.co.uk/goto/2015asthma-copd38.asp

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group Ltd
+44 (0) 20 7827 6162
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.